Drug Product manufacturing
Amid the new wave of pharmaceutical innovation, small molecule drugs are regaining momentum. As more highly potent, poorly soluble, and precisely targeted compounds enter development pipelines, drug product development is evolving from a manufacturing step into a strategic bridge connecting science and clinical performance, pursuing greater precision, intelligence, and regulatory excellence to maximize the value of each molecule.
Leveraging its deep expertise and forward-looking strategy in small molecule development, ChemExpress offers a one-stop small molecule drug product manufacturing platform. Guided by science, driven by efficiency, and committed to quality, we empower global partners to accelerate the clinical and commercial realization of innovative small-molecule therapies.
One-Stop Small Molecule
CDMO Platform
From R&D to commercialization, we integrate CRO & CDMO capabilities across small molecules—delivering end-to-end services in RSM, intermediate, API, HPAPI and drug products.
Green Chemistry &
Enabling Technology
We specialize in complex chemistry—chiral molecules, HPAPI, heterocycles, ADC linkers, and etc.—with enabling technologies including flow chemistry, High Throughput Experimentation, biocatalysis, and Solubility-Enhancing Technologies.
Global Compliance &
Cost Efficiency
With Multiple GMP-compliant sites, we ensure regulatory excellence. Our tailored CDMO strategies help reduce costs, minimize tech transfer, and accelerate the path to market.
Our Services
Our expert team combines advanced technology platforms with extensive project experience to deliver end-to-end drug product manufacturing services spanning pre-formulation, formulation process development, clinical supply, process validation, and commercialization. ChemExpress is dedicated to being your most reliable and value-driven CDMO partner.
Our Service Scope Includes
Drug Product Manufacturing Solutions
- Pilot-scale Production and Registration Batch Manufacturing
- Production of Clinical Trial Samples
- Development and Production of Placebos
- Hormone Topical Preparations
- Contract Commercial Manufacturing for Marketing Authorization Holder (MAH)
- Repackaging, Blinding, and Labeling of Clinical Samples
- Transfer and Validation of Analytical Methods
- Stability Studies
Drug Product cGMP Capacity
- Formulation Development and Manufacturing: tablets, hard capsules, granules, powders, creams, ointment and gels, including anti-tumor drugs and topical hormone preparations
- Oral Solid Dosages: 4 commercial-scale workshops, ~1 billion units per year
- Semi-solid Topical Dosages: 3 commercial-scale workshops, total capacity~50 million tubes per year
- Solid Dispersion: 1 large scale topical preparation line
- Batch Size Supported: ~3,000 to ~3,000,000 units (tablets/capsules)
Why Partner with ChemExpress
Our Sites
Manufacturing Site
FAQs
The batch size ranges from about 3,000 tablets/capsules to 3,000,000 tablets/capsules, depending on the specific product and manufacturing process.
We support dosage forms such as oral solid tablets, capsules, granules, powders, and topical semi-solid creams, ointments, and gels.